REPORT: Major Chinese firm to invest $500m in Dundalk


Pharma company
According to a report in today's Sunday Business Post, a Chinese pharmaceutical company is set to invest $500m in building a new facility in Dundalk.
The report says that in a big coup for the IDA, pharma giant WuXi AppTec is preparing to build a new facility in Dundalk.
Sources suggest there could be hundreds of jobs on the way for Dundalk.
Established in December 2000, WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform with global operations.
As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process.
The company's services are designed to help worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.
The company is actively improving its capabilities and capacity through new expansions in its global business.
Capitalizing on the great advantage of conducting R&D services, WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.